Abstract
This study was to investigate the effect of nicotine on insulin sensitivity and explore the underlying mechanisms. Treatment of Sprague-Dawley rats with nicotine (3 mg/kg/day) for 6 weeks reduced 43% body weight gain and 65% blood insulin level, but had no effect on blood glucose level. Both insulin tolerance test and glucose tolerance test demonstrated that nicotine treatment enhanced insulin sensitivity. Pretreatment of rats with hexamethonium (20 mg/kg/day) to antagonize peripheral nicotinic receptors except for α7 nicotinic acetylcholine receptor (α7-nAChR) had no effect on the insulin sensitizing effect of nicotine. However, the insulin sensitizing effect but not the bodyweight reducing effect of nicotine was abrogated in α7-nAChR knockout mice. Further, chronic treatment with PNU-282987 (0.53 mg/kg/day), a selective α7-nAChR agonist, significantly enhanced insulin sensitivity without apparently modifying bodyweight not only in normal mice but also in AMP-activated kinase-α2 knockout mice, an animal model of insulin resistance with no sign of inflammation. Moreover, PNU-282987 treatment enhanced phosphorylation of signal transducer and activator of transcription 3 (STAT3) in skeletal muscle, adipose tissue and liver in normal mice. PNU-282987 treatment also increased glucose uptake by 25% in C2C12 myotubes and this effect was total abrogated by STAT3 inhibitor, S3I-201. All together, these findings demonstrated that nicotine enhanced insulin sensitivity in animals with or without insulin resistance, at least in part via stimulating α7-nAChR-STAT3 pathway independent of inflammation. Our results contribute not only to the understanding of the pharmacological effects of nicotine, but also to the identifying of new therapeutic targets against insulin resistance.
Highlights
Insulin resistance occurs in 20%–25% of the human population [1]
We were surprised to find that chronic nicotine treatment can significantly reduce HOMA of insulin resistance (HOMA-IR) in normal rats, suggesting that nicotine may enhance insulin sensitivity [16]
Results from both Insulin tolerance test (ITT) and Glucose tolerance test (GTT) confirmed that chronic nicotine treatment enhanced insulin sensitivity in normal rats
Summary
Insulin resistance occurs in 20%–25% of the human population [1]. It is a chief component of type 2 diabetes mellitus and an important risk factor for cardiovascular disease as well as certain forms of cancer [2,3,4,5]. Clinical studies reported that nicotine infusion acutely impairs insulin sensitivity in type 2 diabetic patients and smokers but not in healthy subjects [10,11]. Long-term nicotine gum or nicotine patch replacement in previous smokers is associated with insulin resistance [12,13]. Animal studies show that long-term oral nicotine administration reduces insulin resistance in obese rats [14]. More evidence for the effect of nicotine on insulin sensitivity is needed to be provided on different animal models and the underlying mechanism is needed to be clarified
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.